• Email Address: hello@greenkeyllc.com
  • Phone Number: 888-368-5336
Submit Your Resume

#WeAreGreenKey: Spotlight on Lauren Scutero

06Jun
Green KeyGeneral Interest, Green Key News, Pharma, Worklife

Welcome back to #WeAreGreenKey, where we shine a spotlight on our powerhouse recruiting team.

Last week, we sat down with Lauren Scutero, Staffing Manager on the Pharma National team. Lauren has about 18 years of pharmaceutical recruiting experience, with no end in sight. She elaborated on the strong relationships she has built in the industry, especially with those she has known since the beginning, as well as why pharmaceutical recruiting is so close to her heart.

How did you first get started in staffing?

In 2004, I started working at a staffing agency in Tennessee. About six months in, I realized I wasn’t too happy working there, so I started applying for jobs in Florida where I wanted to relocate. I was eventually recruited for a pharmaceutical staffing agency, where I met Larry [Goodman] and Deloris [Jones]. I got the offer and started working with them in November 2004. Ten years later, I was lucky enough to make the move to their team at Green Key. My team has always felt like family because they are.

What do you love about recruiting for Pharma?

I love that we are making a difference in this field. On a personal level, my son was diagnosed with Type 1 Diabetes when he was two years old. It made my work so much more real to me knowing there are people, especially children, who our work is helping in the long run. It is so close to my heart at this point. My son’s life is impacted by the people who we place.

What makes your team so successful?

We are a family, but still competitive with each other. We have fun with it, while also building each other up. Our team cares about each other as people, not just coworkers. All the new recruiters know they will have our support from the very beginning.

What is the training like on your team?

They run through the Salesforce training in the first week and then in their second week, they hop on a Teams call with each of the Senior Recruiters. We provide examples of resumes, top positions we recruit for, day-to-day operations, and different types of interviews. Once they really jump into it, we do follow up calls to check-in and answer any questions they may have.

What do you believe sets Green Key apart from other staffing agencies?

It’s family from the top down. Even from upper management, I get messages from the Partners asking how things are going in my personal and professional life. Our agency has grown, but it still feels Iike a family-oriented company. The work-life balance is tremendous and it’s all because of our management team.

What are your goals for yourself and your team in the new year?

Clinical research doesn’t go anywhere. We must continue pushing forward and keep showing our clients that Green Key is one of the top recruiting/staffing agencies around. It is not just the daily grind; we have to remember the bigger picture and the difference we are making in the world.

Related Post

Pharma
Jun 6, 2023

Drug Industry Invests $1 Billion For Antibiotic Development

Pharma
Jun 6, 2023

Drug Industry Invests $1 Billion For Antibiotic Development

Before the discovery of antibiotics, tuberculosis was the second most common cause of death in the US. Today, thanks to antibiotics, the few who contract the disease rarely die.

But as TB and other once-easily cured diseases grow increasingly antibiotic resistant, the very real fear is that medicine may run out of treatment options, leading to epidemics dwarfing COVID-19.

To head-off that kind of future, two dozen pharmaceutical firms have invested nearly $1 billion creating the AMR Action Fund with the goal of developing 2-4 new antibiotics by 2030.

AMR – antimicrobial resistance – arises when infectious disease pathogens become resistant to existing medicines. Tuberculosis is one of them, as are several others including the much publicized MRSA.

“AMR has the potential to render diseases that are relatively easy to treat today virtually incurable,” said Dr. Paul Stoffels, vice chairman of the executive committee and chief scientific officer, Johnson & Johnson.

“Left unchecked, AMR could significantly eclipse the global health challenge that the world is facing currently with COVID-19,” he said in a statement announcing the launch of the AMR Action Fund.

The initial funding pledges from the bioscience and drug firms – including $100 million pledged each by Johnson & Johnson and Pfizer – will be supplemented by non-industry partners, the Fund says on its website.

Explaining that “drug resistant bacteria are developing faster than new antibiotics can reach the market,” the Fund says there are few antibiotics in clinical development to meet current and anticipated needs. The reason is that the market for antibiotics “doesn’t support the level of investment needed to maintain a robust antibiotic pipeline.”

The website goes on to explain that smaller biotech firms have trouble financing trials of the antibiotics they do develop. Some that have developed new antibiotics “have declared bankruptcy or exited this space,” cautions the Fund, “Due to the lack of commercial sustainability, resulting in the loss of valuable expertise and resources.”

To achieve its goal of bringing to market the new antibiotics in a decade, the Fund said it “will invest in smaller biotech companies focused on developing new antibiotics that address the highest priority public health needs.”

Specifically, the AMR Action Fund will:

  1. “Invest based on the WHO/CDC priority lists of pathogens, with the goal to address major unmet needs and maximize public health impact.
  2. “Prioritize novel antibacterial treatments, as recognized by leading public health agencies, with significant and differentiated clinical utility and that reduces patient mortality.
  3. “Invest across all stages of clinical development.”

[bdp_post_carousel]

Read Continue
 
Required 'Candidate' login to applying this job. Click here to logout And try again
 
 

Answers

 

Account Activation

Before you can login, you must activate your account with the code sent to your email address. If you did not receive this email, please check your junk/spam folder. Click here to resend the activation email. If you entered an incorrect email address, you will need to re-register with the correct email address.